key: cord-0942403-dtadac1y
authors: Guo, Yaqiong; Luo, Ronghua; Wang, Yaqing; Deng, Pengwei; Song, Tianzhang; Zhang, Min; Wang, Peng; Zhang, Xu; Cui, Kangli; Tao, Tingting; Li, Zhongyu; Chen, Wenwen; Zheng, Yongtang; Qin, Jianhua
title: SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip
date: 2020-12-01
journal: Sci Bull (Beijing)
DOI: 10.1016/j.scib.2020.11.015
sha: 1afd8874ce8b72849e3ed73cd85d0b903a3386f7
doc_id: 942403
cord_uid: dtadac1y

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. Clinical evidence suggests that the intestine is another high-risk organ for SARS-CoV-2 infection besides the lungs. However, a model that can accurately reflect the response of the human intestine to the virus is still lacking. Here, we created an intestinal infection model on a chip that allows the recapitulation of human relevant intestinal pathophysiology induced by SARS-CoV-2 at organ level. This microengineered gut-on-chip reconstitutes the key features of the intestinal epithelium-vascular endothelium barrier through the three-dimensional (3D) co-culture of human intestinal epithelial, mucin-secreting, and vascular endothelial cells under physiological fluid flow. The intestinal epithelium showed permissiveness for viral infection and obvious morphological changes with injury of intestinal villi, dispersed distribution of mucus-secreting cells, and reduced expression of tight junction (E-cadherin), indicating the destruction of the intestinal barrier integrity caused by virus. Moreover, the vascular endothelium exhibited abnormal cell morphology, with disrupted adherent junctions. Transcriptional analysis revealed abnormal RNA and protein metabolism, as well as activated immune responses in both epithelial and endothelial cells after viral infection (e.g., upregulated cytokine genes), which may contribute to the injury of the intestinal barrier associated with gastrointestinal symptoms. This human organ system can partially mirror intestinal barrier injury and the human response to viral infection, which is not possible in existing in vitro culture models. It provides a unique and rapid platform to accelerate COVID-19 research and develop novel therapies.

Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. Clinical evidence suggests that the intestine is another high-risk organ for SARS-CoV-2 infection besides the lungs. However, a model that can accurately reflect the response of the 

Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global epidemic. As of late August 2020, it has caused 22 million infections and more than 790,000 deaths. SARS-CoV-2 infection is characterized by a process ranging from asymptomatic and mild disease to severe systemic symptoms involving multiple organs, most notably the lung and gastrointestinal tract, and finally, multi-organ failure [1] . Respiratory symptoms dominate the clinical manifestations of COVID-19, yet obvious gastrointestinal symptoms are observed in 20% to 50% of patients. These include abdominal pain, diarrhea, hematochezia, and even intestinal perforation [2] [3] [4] [5] . These symptoms sometimes appear before the onset of respiratory symptoms [6] . In addition, biopsy samples show a large number of interstitial edema plasma cells and lymphocytes infiltrated into the lamina propria of the stomach, duodenum, and rectum [7] . It has been reported that SARS-CoV-2 can cause acute hemorrhagic colitis, thus providing evidence implicating the gastrointestinal tract in the transmission of SARS-CoV-2 infection [8] . Moreover, viral RNA has been identified in the stool samples of COVID-19 patients, and typical coronavirus virions have been observed in rectal tissue using electron microscopy, implying that SARS-CoV-2 may potentially be transmitted via the fecal-oral route [9] [10] [11] . These clinical evidences suggest that the intestine is another high-risk organ for SARS-CoV-2 infection besides the lungs, but the pathogenesis of the intestinal infection in COVID-19 is not known.

The human intestine contains complex multicellular components and host-pathogen interactions in a physiological flow microenvironment with mechanical cues.

Currently, SARS-CoV-2 infection in the intestine is studied based on monolayer cultures of intestinal epithelial cells [12, 13] and human organoids [14, 15] . However, these in vitro models have limitations. Monolayer cell culture systems are oversimplified and cannot recapitulate the multiple cellular components, complex structure, and functions of the native intestine. Moreover, they lack cell-cell/matrix interactions and the tissue-specific dynamic microenvironment that exist in vivo.

Recently, intestinal organoids have provided a new in vitro three dimensional (3D) model of studying SARS-CoV-2 infection, by providing multiple cell types and supporting viral replication in gut enterocytes [14] . However, these organoids are still limited by a lack of the typical characteristics of the intestinal barrier, the extracellular matrix (ECM), immune cells, and physiological flow, which are key features of the intestinal microenvironment. As such, it is highly desirable to develop alternative in vitro models to better reflect the pathophysiology of SARS-CoV-2 infection in human organs.

Organ-on-a-chip technology has evolved to provide the possibility to reproduce the complex structures and physiological functions of human organs in an engineered microfluidic culture device [16] [17] [18] . It has been used to represent organ-level physiology and pathology, and applied in various biomedical applications, including organ engineering, disease studies, and drug testing [19] [20] [21] [22] . For example, human gut-on-chip systems have been used to study drug metabolism [23] , host-microbiome interactions [24] [25] [26] , and coxsackie B1 virus infection [27] . In this study, we built an 

The human intestinal model consisted of upper and lower layers fabricated using conventional soft lithography procedures. The PDMS pre-polymer was prepared by mixing 10:1 (wt/wt) PDMS base with a curing agent (184 Silicone Elastomer, Dow Corning Co., Midland, MI, USA) and casted on molds to produce a molded device with channels by thermal curing at 80 °C for 45 min. The channels were 1.5 mm wide × 0.25 mm high, and the length of overlapping channels was 8 mm. The two channels were separated by a thin (~25 m) through-hole PDMS membrane (pore size: 5 μm, gaps between pores: 70 μm) to construct tissue-tissue interfaces. The density of the porous PDMS membrane was approximately 12,000 pores/cm 2 . The membrane was sandwiched in the gut-on-chip device by oxygen plasma bonding. Finally, the devices were exposed to ultraviolet light for disinfection and sterilization. Prior to cell seeding, both sides of the porous membrane were coated with rat tail collagen type I (200 μg/mL, Corning) and incubated at 37 °C for 48 h. After cell attachment, cells were grown to confluence for 5 days and the chips were maintained in an incubator with 5% CO 2 at 37 °C. 

Caco-2 cells were seeded in 24-well plates (~2 × 10 5 

Caco-2 cells cultured in a 24-well plate were washed with PBS and fixed with 4% PFA at 4 ℃ overnight. Cells were then permeabilized with 0.2% Triton X-100 in PBS (PBST buffer) for 5 min and blocked with PBST buffer containing 5% normal goat serum for 30 min at room temperature. Antibodies were diluted with PBST buffer.

Cells were stained with corresponding primary antibodies at 4℃ overnight and with secondary antibodies (Table S1 online) at room temperature for 1 h. After staining with secondary antibodies, cell nuclei were counterstained with DAPI. For immunofluorescent imaging of the intestinal model, cells were washed with PBS through the upper and lower channels and fixed with 4% PFA. The fixed tissues were subjected to immunofluorescence staining using the procedure described above. All images were acquired using a confocal fluorescence microscope system (FV-1000;

Olympus, Tokyo, Japan). Image processing was performed using ImageJ (National Institutes of Health, Bethesda, MD, USA).

Intestinal epithelial cells and endothelial cells were collected from the chips separately. Total RNA was extracted from samples using TRIzol (Invitrogen, Carlsbad, CA, USA) and RNA quality was determined using a Nanodrop TM OneC spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). RNA integrity was confirmed by 1.5% agarose gel electrophoresis. Qualified RNAs were quantified using a Qubit3.0 instrument, with the Qubit TM RNA Broad Range Assay kit (Life Technologies, Carlsbad, CA, USA). One hundred nanograms of total RNA was used for stranded RNA sequencing library preparation using the KC-Digital TM Table S1 (online).

Trimmomatic (version 0.36) was used to filter the raw sequencing data (discard low-quality reads and trim the reads contaminated with adaptor sequences). Clean reads were further processed with in-house scripts to eliminate the duplication bias introduced during library preparation and sequencing. In brief, clean reads were first clustered according to their UMI sequences, in which reads with the same UMI sequence were grouped into the same cluster, resulting in 65,536 clusters. Reads in the same cluster were compared to each other by pairwise alignment, and then reads with a sequence identity greater than 95% were extracted to a new sub-cluster. After all sub-clusters were generated, multiple sequence alignment was performed to obtain one consensus sequence for each sub-cluster. After these steps, any errors and biases introduced by PCR amplification or sequencing were discarded.

RNA-sequencing analysis was performed on the de-duplicated consensus sequences, which were mapped to the Homo sapiens reference genome from the 

Data were collected in Excel (Microsoft, Redmond, WA, USA). Differences between two groups were analyzed using a Student's t-test. Multiple group comparisons were performed using a one-way analysis of variance (ANOVA) followed by post-hoc tests.

The bar graphs with error bars represent the mean ± standard deviation (SD).

Significance is indicated by asterisks: *, P < 0.05; **, P < 0.01; ***, P < 0.001.

In vivo, the human intestinal epithelium is a cell monolayer that constitutes the intestinal barrier, which allows mucus secretion and nutrient absorption while showed that both ZO-1 and E-cadherin were expressed in the epithelium (Fig. 2a) .

Moreover, confocal micrographs of the full-sized scan showed that the epithelial cells formed adherent junctions (E-cadherin) and endothelial cells formed conjunctions (VE-cadherin, Fig. S2 online) . In particular, the epithelial cells formed villus-like structures lined with a highly polarized columnar epithelium identified by differential interference contrast (DIC) imaging. These structures were similar to intestinal villi in vivo (Fig. 2c) . Moreover, the endothelial integrity was examined by ZO-1 and VE-cadherin immunostaining, which showed the regular and intact distribution of junction proteins (Fig. 2b) . As the intestinal mucus layer is the crucial interface between the host and microbes, it plays a vital role in preventing microbial invasion [28] . We examined mucus production in the intestinal epithelium by immunostaining using a mucin-specific marker (MUC2). As shown in Fig. 2d, a 

Prior to SARS-CoV-2 infection of the gut-on-chip, we first detected the expression levels of ACE2 and TMPRSS2 in three cell lines, Caco-2 cells, HT-29 cells, and HUVECs, by western blotting. SARS-CoV-2 is known to use ACE2 as a receptor for cellular entry and the protease TMPRSS2 for viral Spike protein priming [29, 30] . Intestinal enterocytes express a higher level of ACE2 than alveolar epithelial type II cells [31] [32] [33] . Among the three cell lines tested in this study, ACE2 and TMPRSS2

were expressed at the highest levels in Caco-2 cells (Fig. S1a online) , which implied Spike-positive cells were predominantly detected in the intestinal layer, indicating that the intestinal epithelial cells were more permissive to SARS-CoV-2 infection than endothelial cells (Fig. 3) .

In vivo, the development and maintenance of the intestinal barrier depends heavily on the proper function of adherent junctions. Therefore, we further examined the adherent junctions of the intestinal epithelium and endothelium. Confocal micrographs of the intestinal epithelium showed that on day 3 after viral infection, the adherent junction, identified by E-cadherin expression, was severely destroyed, and this was accompanied by damage to the intestinal villus-like structures (Fig. 3a) .

Furthermore, the mucus-secreting cells in the intestinal epithelium were examined by immunostaining of MUC2. The clonal distribution of MUC2 + cells became dispersed after viral infection (Fig. 4a) . This suggested that the disturbed intestinal mucus layer was caused by viral infection, which may lead to virus encroachment and infection. It was noted that on the vascular side, the adherent junctions between endothelial cells were severely disrupted, as indicated by VE-cadherin immunostaining (Fig. 4b) .

Quantitative analysis showed that the density and size of endothelial cells were significantly decreased (Fig. 4c and d) . This indicated that vascular endothelial cell injury occurred following viral infection, but there were no obvious Spike-positive cells on the vascular side. The presence of endothelial injury may partially explain the pathogenesis of COVID-19-associated coagulopathy or vascular thrombosis [34] . To investigate the host biological pathways modified by SARS-CoV-2 infection, KEGG pathway enrichment analysis was performed, comparing mock-infected versus SARS-CoV-2-infected gut-on-chip systems (Fig. 5c and d) . In both cell types, viral infection resulted in abnormal pathway networks, including RNA metabolism pathways (e.g., spliceosome, RNA transport, RNA degradation, and mRNA surveillance) and protein metabolism pathways (e.g., ubiquitin-mediated proteolysis and protein export). Given the vital roles of RNA and protein metabolism in maintaining the normal physiological functions of cells, we reasoned that SARS-CoV-2 may seriously affect the host cells by disrupting these critical pathways.

In addition, we found that some immune response-related pathways, such as tumor necrosis factor (TNF) signaling pathway and NF-kappa B signaling pathway, were particularly enriched in genes that were significantly upregulated in endothelial cells, which indicated that intestinal endothelial cells play critical roles in mediating intestinal immune responses.

KEGG pathway enrichment analysis indicated that some immune response-related signaling pathways were activated following SARS-CoV-2 infection. We then aimed to identify the upregulated cytokine genes that mediated the subsequent inflammatory responses of the intestine to SARS-CoV-2 infection. The heat map showed that SARS-CoV-2 infection elicited extensive cytokine induction in both the intestinal epithelium and endothelium. Induced cytokines included TNF, interleukins, chemokines, and colony-stimulating factors, in both intestinal epithelial and endothelial cells (Fig. 6a and b) . Notably, in this infected intestinal model, some cytokines, including TNF, IL-6, CXCL10, CCL5, and CSF3, were significantly upregulated, which is similar to the clinical manifestation of patients with severe COVID-19 [35, 36] . These results may partially explain the presence of infiltrated immune cells and the inflammatory response in the intestine of patients with severe COVID-19.

We then further analyzed the expression of pro-inflammatory cytokine-and chemokine-related genes in intestinal epithelial cells by qRT-PCR. The expression levels of CCL5, CXCL1, CXCL10, and CXCL11 were significantly upregulated in SARS-CoV-2-infected epithelial cells (Fig. 6c) . These data indicated that chemokine genes can be induced by SARS-CoV-2, and this may play a crucial role in the recruitment of immune cells and the modulation of the immune response to viral infection. It has previously been reported that the chemokine, CCL5, recruits T cells, dendritic cells, eosinophils, natural killer cells, mast cells, and basophils [37] , CXCL1 recruits neutrophils [38] ; CXCL10 recruits activated Th1 lymphocytes [39] ; and CXCL11 recruits interleukin-activated T-cells [40] to sites of inflammation. This may provide clues to further identify the specific immune cells that are involved in the intestinal inflammatory responses during the progression of COVID-19.

In this study, we created a biomimetic human gut-on-chip system that can mirror the In addition, we found that the intestinal epithelium was more permissive to SARS-CoV-2 infection than the endothelium on the chip, which is consistent with previous studies [12] . As such, we propose that the observed vascular endothelial injury may be mediated by inflammatory factors or paracrine signals released by virus-infected intestinal epithelial cells.

Certainly, this study has some limitations. One potential limitation is the use of immortalized intestinal epithelial cell lines (e.g., Caco-2) originally isolated from human colon tumors. However, Caco-2 cells have been widely used to recapitulate many physiological and pathological functions of the human intestine in vivo [42, 43] . 

Conclusively, this work provides the first proof-of-concept for building a human intestinal SARS-CoV-2 infection model using a biomimetic gut-on-a-chip that closely mirrors the pathophysiology and intestine-specific responses at the organ level in vitro.

The novelty of this work lies in its capability to reproduce the organ-specific intestinal microenvironment and human-relevant responses to SARS-CoV-2 on a chip system. This was achieved by integrating complex multicellular components, an intestinal tissue barrier, and physiological fluid flow, which cannot be easily achieved with other in vitro culture models. This intestinal microphysiological system not only offers a unique, rapid, and low-cost platform for the study of viral infection, transmission, host-virus interactions, and disease pathogenesis in a more realistic manner, but also provides a complement to animal models. This system is expected to accelerate COVID-19 research and the development of novel therapeutics, which are critical during the SARS-CoV-2 pandemic crisis.

All relevant data are available in the manuscript or the supporting information. All of the RNA-sequencing raw data have been deposited in the Sequence Read Archive under the accession number PRJNA658711.

The authors declare that they have no conflict of interest. Student's t-test (*, P < 0.05; **, P < 0.01, ***, P < 0.001; n = 3).

Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review

Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management

COVID-19 and the gastrointestinal tract: more than meets the eye

Enteric involvement in hospitalised patients with COVID-19 outside Wuhan

SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19

Evidence for gastrointestinal infection of SARS-CoV-2

The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19

Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis

COVID-19: faecal-oral transmission?

Direct evidence of active SARS-CoV-2 replication in the intestine

Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

SARS-CoV-2 productively infects human gut enterocytes

Infection of bat and human intestinal organoids by SARS-CoV-2

Microfluidic organs-on-chips

Engineering a perfusable 3D human liver platform from iPS cells

Advances in organ-on-a-chip engineering

Reconstituting organ-level lung functions on a chip

A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice

Engineering human islet organoids from iPSCs using an organ-on-chip platform

Robotic fluidic coupling and interrogation of multiple vascularized organ chips

A biomimetic human gut-on-a-chip for modeling drug metabolism in intestine

A microfluidics-based in vitromodel of the gastrointestinal human-microbe interface

A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip

A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies

Human gut-on-a-chip supports polarized infection of coxsackie B1 virus in vitro

The role of the immune system in governing host-microbe interactions in the intestine

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

A pneumonia outbreak associated with a new coronavirus of probable bat origin

The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization. bioRxiv

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Targeting CCL5 in inflammation

Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

CXCL10, CXCL11/CXCR3 axis for immune activation-a target for novel cancer therapy

SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip

A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium

Yaqiong Guo is a Ph.D. candidate at Dalian Institute of Chemical Physics, Chinese Academy of Sciences. She received her B.S. degree from Central China Normal University in 2014

His research mainly focuses on preclinical evaluation and mechanisms of antiviral compounds

She received her B.E. degree from Harbin Institute of Technology in 2012

Pengwei Deng is a Ph.D. candidate at Dalian Institute of Chemical Physics, Chinese Academy of Sciences. He received his B.S degree from Huazhong University of Science and Technology in 2016